| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.629 | 0.008 | 0.629 | 5 Hydroxytryptamine release inhibitor | 0.529 0.024 DBMET01702 | ||
| 0.62 | 0.016 | 0.62 | Aldehyde oxidase inhibitor | 0.45 0.04 DBMET01702 | ||
| 0.607 | 0.018 | 0.625 | Cholesterol antagonist | 0.625 0.015 DBMET01702 | DBMET01702 | |
| 0.574 | 0.011 | 0.574 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.457 0.057 DBMET01702 | ||
| 0.554 | 0.016 | 0.554 | Histamine release inhibitor | 0.477 0.037 DBMET01702 | ||
| 0.504 | 0.005 | 0.539 | Alpha-N-acetylglucosaminidase inhibitor | 0.539 0.005 DBMET01702 | DBMET01702 | |
| 0.442 | 0.004 | 0.543 | Porphobilinogen synthase inhibitor | 0.543 0.003 DBMET01702 | DBMET01702 | |
| 0.44 | 0.004 | 0.44 | Succinate dehydrogenase inhibitor | 0.35 0.005 DBMET01702 | ||
| 0.439 | 0.003 | 0.439 | Ferrochelatase inhibitor | 0.323 0.006 DBMET01702 | ||
| 0.434 | 0.003 | 0.434 | Dihydroorotate dehydrogenase inhibitor | 0.347 0.003 DBMET01702 | ||
| 0.43 | 0.002 | 0.43 | Dihydroorotase inhibitor | 0.161 0.004 DBMET01702 | ||
| 0.463 | 0.044 | 0.513 | Calcium channel L-type activator | 0.513 0.023 DBMET01702 | DBMET01702 | |
| 0.391 | 0.014 | 0.391 | Non-steroidal antiinflammatory agent | 0.329 0.023 DBMET01702 | ||
| 0.366 | 0.006 | 0.366 | GABA C receptor agonist | 0.218 0.017 DBMET01702 | ||
| 0.364 | 0.004 | 0.364 | Alcohol oxidase inhibitor | 0.173 0.008 DBMET01702 | ||
| 0.381 | 0.032 | 0.381 | Calcium channel activator | 0.342 0.055 DBMET01702 | ||
| 0.455 | 0.108 | 0.513 | Antiinflammatory | 0.513 0.082 DBMET01702 | DBMET01702 | |
| 0.332 | 0.003 | 0.332 | Biliverdin reductase inhibitor | 0.237 0.004 DBMET01702 | ||
| 0.36 | 0.034 | 0.36 | Superoxide dismutase inhibitor | 0.236 0.084 DBMET01702 | ||
| 0.329 | 0.008 | 0.329 | M17 leucyl aminopeptidase inhibitor | 0.251 0.02 DBMET01702 | ||
| 0.328 | 0.008 | 0.328 | Hexokinase inhibitor | 0.309 0.01 DBMET01702 | ||
| 0.343 | 0.025 | 0.343 | Anesthetic general | 0.253 0.049 DBMET01702 | ||
| 0.315 | 0.004 | 0.315 | Keratolytic | 0.28 0.004 DBMET01702 | ||
| 0.315 | 0.004 | 0.335 | Triose-phosphate isomerase inhibitor | 0.335 0.004 DBMET01702 | DBMET01702 | |
| 0.311 | 0.005 | 0.363 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.363 0.004 DBMET01702 | DBMET01702 | |
| 0.324 | 0.019 | 0.324 | Gastrin inhibitor | 0.274 0.053 DBMET01702 | ||
| 0.32 | 0.018 | 0.32 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.3 0.024 DBMET01702 | ||
| 0.305 | 0.004 | 0.305 | Electrolyte absorption antagonist | 0.199 0.008 DBMET01702 | ||
| 0.313 | 0.018 | 0.313 | Interferon gamma antagonist | 0.276 0.024 DBMET01702 | ||
| 0.299 | 0.01 | 0.336 | UDP-glucose 4-epimerase inhibitor | 0.336 0.009 DBMET01702 | DBMET01702 | |
| 0.401 | 0.114 | 0.42 | Alpha-glucosidase inhibitor | 0.42 0.106 DBMET01702 | DBMET01702 | |
| 0.307 | 0.022 | 0.307 | Mcl-1 antagonist | 0.248 0.037 DBMET01702 | ||
| 0.29 | 0.006 | 0.29 | Mannose-6-phosphate isomerase inhibitor | 0.282 0.007 DBMET01702 | ||
| 0.358 | 0.082 | 0.358 | GABA C receptor rho-3 antagonist | 0.234 0.169 DBMET01702 | ||
| 0.311 | 0.039 | 0.311 | 5 Hydroxytryptamine uptake stimulant | 0.281 0.056 DBMET01702 | ||
| 0.281 | 0.015 | 0.338 | Insulin secretagoues | 0.338 0.009 DBMET01702 | DBMET01702 | |
| 0.314 | 0.05 | 0.314 | Insulysin inhibitor | 0.222 0.127 DBMET01702 | ||
| 0.295 | 0.037 | 0.295 | MAP kinase kinase 2 inhibitor | 0.244 0.057 DBMET01702 | ||
| 0.373 | 0.128 | 0.373 | DNA directed DNA polymerase inhibitor | 0.232 0.203 DBMET01702 | ||
| 0.267 | 0.028 | 0.267 | Diuretic | 0.127 0.097 DBMET01702 | ||
| 0.277 | 0.042 | 0.277 | Peroxidase inhibitor | 0.127 0.093 DBMET01702 | ||
| 0.281 | 0.058 | 0.332 | Interleukin agonist | 0.332 0.034 DBMET01702 | DBMET01702 | |
| 0.294 | 0.074 | 0.298 | Lipoxygenase inhibitor | 0.298 0.072 DBMET01702 | DBMET01702 | |
| 0.229 | 0.012 | 0.229 | Adenylate kinase inhibitor | 0.202 0.015 DBMET01702 | ||
| 0.303 | 0.085 | 0.311 | Vasodilator, coronary | 0.311 0.079 DBMET01702 | DBMET01702 | |
| 0.23 | 0.014 | 0.297 | Carbonic anhydrase XV inhibitor | 0.297 0.008 DBMET01702 | DBMET01702 | |
| 0.222 | 0.009 | 0.222 | NADH dehydrogenase inhibitor | 0.197 0.011 DBMET01702 | ||
| 0.282 | 0.069 | 0.282 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.316 | 0.105 | 0.316 | Immunosuppressant | 0.299 0.115 DBMET01702 | ||
| 0.346 | 0.141 | 0.346 | DNA polymerase beta inhibitor | |||
| 0.219 | 0.016 | 0.219 | Interleukin 1b antagonist | 0.146 0.043 DBMET01702 | ||
| 0.212 | 0.009 | 0.212 | HIV-1 integrase (Overall Integration) inhibitor | 0.203 0.011 DBMET01702 | ||
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.202 0.031 DBMET01702 | ||
| 0.248 | 0.048 | 0.248 | DNA methyltransferase I inhibitor | 0.207 0.066 DBMET01702 | ||
| 0.259 | 0.06 | 0.259 | Tyrosine 3 hydroxylase inhibitor | 0.207 0.124 DBMET01702 | ||
| 0.341 | 0.142 | 0.341 | MAP kinase 1 inhibitor | 0.261 0.221 DBMET01702 | ||
| 0.208 | 0.009 | 0.208 | Creatine kinase inhibitor | 0.15 0.024 DBMET01702 | ||
| 0.259 | 0.061 | 0.298 | DNA synthesis inhibitor | 0.298 0.044 DBMET01702 | DBMET01702 | |
| 0.307 | 0.11 | 0.307 | Calpain 2 inhibitor | 0.207 0.181 DBMET01702 | ||
| 0.21 | 0.015 | 0.21 | Cyclooxygenase 3 inhibitor | 0.194 0.021 DBMET01702 | ||
| 0.228 | 0.035 | 0.228 | Heat shock protein 90 alpha antagonist | |||
| 0.226 | 0.033 | 0.272 | Protein kinase stimulant | 0.272 0.021 DBMET01702 | DBMET01702 | |
| 0.191 | 0.005 | 0.191 | NMDA receptor agonist | 0.133 0.01 DBMET01702 | ||
| 0.241 | 0.056 | 0.241 | Death-associated protein kinase 3 inhibitor | 0.195 0.078 DBMET01702 | ||
| 0.202 | 0.018 | 0.202 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.161 0.054 DBMET01702 | ||
| 0.196 | 0.013 | 0.278 | Histidine decarboxylase inhibitor | 0.278 0.007 DBMET01702 | DBMET01702 | |
| 0.216 | 0.035 | 0.216 | Lipid peroxidase inhibitor | 0.21 0.037 DBMET01702 | ||
| 0.206 | 0.026 | 0.206 | MAP kinase kinase inhibitor | 0.172 0.04 DBMET01702 | ||
| 0.277 | 0.101 | 0.277 | Sodium/bile acid cotransporter inhibitor | 0.225 0.156 DBMET01702 | ||
| 0.183 | 0.011 | 0.183 | Glutamate dehydrogenase inhibitor | 0.149 0.016 DBMET01702 | ||
| 0.179 | 0.008 | 0.179 | MAP kinase kinase 1 inhibitor | 0.155 0.015 DBMET01702 | ||
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.168 0.014 DBMET01702 | ||
| 0.187 | 0.018 | 0.187 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.048 DBMET01702 | ||
| 0.201 | 0.034 | 0.201 | Cyclooxygenase 1 inhibitor | 0.161 0.051 DBMET01702 | ||
| 0.208 | 0.042 | 0.208 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.205 | 0.04 | 0.205 | Phospholipase A2 inhibitor | 0.195 0.045 DBMET01702 | ||
| 0.226 | 0.063 | 0.226 | DNA methylase inhibitor | 0.196 0.081 DBMET01702 | ||
| 0.17 | 0.008 | 0.17 | CC chemokine 6 receptor antagonist | 0.16 0.012 DBMET01702 | ||
| 0.188 | 0.027 | 0.188 | Protein kinase (CK2) alpha inhibitor | 0.137 0.05 DBMET01702 | ||
| 0.191 | 0.03 | 0.191 | Aldehyde dehydrogenase inhibitor | 0.186 0.031 DBMET01702 | ||
| 0.226 | 0.068 | 0.226 | RNA-directed DNA polymerase inhibitor | 0.226 0.068 DBMET01702 | ||
| 0.185 | 0.027 | 0.185 | Cathepsin H inhibitor | 0.148 0.048 DBMET01702 | ||
| 0.165 | 0.01 | 0.165 | Argininosuccinate synthase inhibitor | 0.133 0.013 DBMET01702 | ||
| 0.181 | 0.026 | 0.181 | Aminopeptidase B inhibitor | 0.15 0.038 DBMET01702 | ||
| 0.166 | 0.01 | 0.166 | Glutamate decarboxylase inhibitor | 0.112 0.024 DBMET01702 | ||
| 0.16 | 0.006 | 0.16 | Purinergic P2X1 antagonist | 0.146 0.008 DBMET01702 | ||
| 0.203 | 0.052 | 0.203 | Tumour necrosis factor antagonist | 0.181 0.066 DBMET01702 | ||
| 0.212 | 0.061 | 0.228 | I kappa B kinase epsilon inhibitor | 0.228 0.05 DBMET01702 | DBMET01702 | |
| 0.204 | 0.054 | 0.204 | Lipocortins synthesis antagonist | 0.17 0.08 DBMET01702 | ||
| 0.175 | 0.024 | 0.175 | Protein kinase (CK2) inhibitor | 0.128 0.043 DBMET01702 | ||
| 0.17 | 0.019 | 0.17 | Gastric antisecretory | 0.161 0.022 DBMET01702 | ||
| 0.154 | 0.004 | 0.154 | NMDA receptor glycine site agonist | 0.117 0.009 DBMET01702 | ||
| 0.2 | 0.051 | 0.2 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.171 | 0.023 | 0.171 | Interleukin 8 antagonist | |||
| 0.17 | 0.022 | 0.17 | Potassium channel (Ca-activated) activator | 0.088 0.066 DBMET01702 | ||
| 0.158 | 0.01 | 0.158 | Prostaglandin-E synthase inhibitor | 0.134 0.015 DBMET01702 | ||
| 0.153 | 0.007 | 0.153 | GABA aminotransferase inhibitor | 0.119 0.017 DBMET01702 | ||
| 0.183 | 0.038 | 0.183 | Cell wall synthesis inhibitor | 0.177 0.042 DBMET01702 | ||
| 0.216 | 0.073 | 0.216 | Pyruvate kinase inhibitor | |||
| 0.158 | 0.018 | 0.158 | Protein kinase C delta inhibitor | 0.155 0.019 DBMET01702 | ||
| 0.157 | 0.017 | 0.162 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.162 0.016 DBMET01702 | DBMET01702 | |
| 0.161 | 0.025 | 0.186 | Carbonic anhydrase III inhibitor | 0.186 0.019 DBMET01702 | DBMET01702 | |
| 0.143 | 0.007 | 0.143 | CDC25B inhibitor | 0.12 0.011 DBMET01702 | ||
| 0.221 | 0.086 | 0.221 | Antiamyloidogenic | 0.169 0.124 DBMET01702 | ||
| 0.156 | 0.021 | 0.158 | Uric acid excretion stimulant | 0.158 0.021 DBMET01702 | DBMET01702 | |
| 0.159 | 0.025 | 0.159 | TRPA1 agonist | 0.105 0.079 DBMET01702 | ||
| 0.167 | 0.034 | 0.167 | Cystathionine beta-synthase inhibitor | 0.106 0.07 DBMET01702 | ||
| 0.144 | 0.012 | 0.148 | Myeloperoxidase inhibitor | 0.148 0.011 DBMET01702 | DBMET01702 | |
| 0.15 | 0.018 | 0.161 | Phosphofructokinase-1 inhibitor | 0.161 0.016 DBMET01702 | DBMET01702 | |
| 0.16 | 0.028 | 0.16 | Heat shock protein 70 antagonist | 0.138 0.083 DBMET01702 | ||
| 0.176 | 0.044 | 0.176 | Interleukin 1 antagonist | |||
| 0.195 | 0.064 | 0.195 | Dual specificity phosphatase 3 inhibitor | 0.168 0.082 DBMET01702 | ||
| 0.151 | 0.021 | 0.151 | GABA C receptor rho-1 antagonist | 0.102 0.059 DBMET01702 | ||
| 0.184 | 0.053 | 0.184 | ATPase inhibitor | |||
| 0.183 | 0.055 | 0.227 | Protein-tyrosine phosphatase inhibitor | 0.227 0.038 DBMET01702 | DBMET01702 | |
| 0.132 | 0.005 | 0.132 | Kainate receptor antagonist | 0.049 0.022 DBMET01702 | ||
| 0.148 | 0.024 | 0.148 | Urease inhibitor | 0.104 0.062 DBMET01702 | ||
| 0.198 | 0.076 | 0.207 | Insulin sensitizer | 0.207 0.066 DBMET01702 | DBMET01702 | |
| 0.146 | 0.026 | 0.146 | Beta glucuronidase inhibitor | 0.107 0.06 DBMET01702 | ||
| 0.125 | 0.005 | 0.125 | Aconitate hydratase inhibitor | 0.083 0.013 DBMET01702 | ||
| 0.142 | 0.023 | 0.19 | Carbonic anhydrase XIII inhibitor | 0.19 0.015 DBMET01702 | DBMET01702 | |
| 0.122 | 0.005 | 0.122 | Nicotinic acid receptor 2 agonist | 0.099 0.005 DBMET01702 | ||
| 0.141 | 0.023 | 0.182 | Carbonic anhydrase VI inhibitor | 0.182 0.015 DBMET01702 | DBMET01702 | |
| 0.149 | 0.032 | 0.159 | Photosensitizer | 0.159 0.026 DBMET01702 | DBMET01702 | |
| 0.144 | 0.027 | 0.144 | Catalase inhibitor | 0.094 0.041 DBMET01702 | ||
| 0.147 | 0.031 | 0.147 | GABA C receptor antagonist | 0.101 0.077 DBMET01702 | ||
| 0.177 | 0.064 | 0.181 | Phospholipase C inhibitor | 0.181 0.06 DBMET01702 | DBMET01702 | |
| 0.168 | 0.056 | 0.206 | Amylase inhibitor | 0.206 0.042 DBMET01702 | DBMET01702 | |
| 0.116 | 0.004 | 0.116 | Dihydroorotate oxidase inhibitor | 0.072 0.015 DBMET01702 | ||
| 0.231 | 0.121 | 0.231 | 12-Lipoxygenase inhibitor | 0.2 0.152 DBMET01702 | ||
| 0.202 | 0.092 | 0.202 | Cyclic AMP phosphodiesterase inhibitor | 0.172 0.119 DBMET01702 | ||
| 0.15 | 0.041 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | 0.145 0.048 DBMET01702 | ||
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | 0.099 0.031 DBMET01702 | ||
| 0.166 | 0.059 | 0.166 | Cyclooxygenase inhibitor | 0.144 0.075 DBMET01702 | ||
| 0.198 | 0.092 | 0.215 | Nitric-oxide synthase stimulant | 0.215 0.067 DBMET01702 | DBMET01702 | |
| 0.3 | 0.194 | 0.317 | Caspase 9 stimulant | 0.317 0.176 DBMET01702 | DBMET01702 | |
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.134 0.051 DBMET01702 | ||
| 0.195 | 0.091 | 0.195 | EphB2 antagonist | |||
| 0.106 | 0.004 | 0.106 | Methionyl aminopeptidase 2 inhibitor | 0.075 0.004 DBMET01702 | ||
| 0.174 | 0.072 | 0.174 | Dual specificity phosphatase inhibitor | 0.145 0.1 DBMET01702 | ||
| 0.161 | 0.06 | 0.161 | GABA C receptor rho-2 antagonist | |||
| 0.111 | 0.011 | 0.111 | Potassium channel (ATP-sensitive) blocker | 0.095 0.018 DBMET01702 | ||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | 0.092 0.014 DBMET01702 | ||
| 0.137 | 0.04 | 0.137 | Protein kinase C gamma inhibitor | 0.137 0.04 DBMET01702 | ||
| 0.131 | 0.034 | 0.131 | DOPA decarboxylase inhibitor | 0.104 0.068 DBMET01702 | ||
| 0.101 | 0.005 | 0.101 | Retinoid X alpha receptor agonist | 0.05 0.014 DBMET01702 | ||
| 0.149 | 0.053 | 0.149 | Farnesoid X receptor antagonist | 0.149 0.053 DBMET01702 | ||
| 0.103 | 0.007 | 0.103 | Cathepsin L2 inhibitor | 0.066 0.015 DBMET01702 | ||
| 0.18 | 0.086 | 0.196 | Growth factor agonist | 0.196 0.067 DBMET01702 | DBMET01702 | |
| 0.099 | 0.005 | 0.099 | Adenine nucleotide translocase inhibitor | 0.095 0.005 DBMET01702 | ||
| 0.097 | 0.003 | 0.097 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.069 0.005 DBMET01702 | ||
| 0.157 | 0.064 | 0.157 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.26 | 0.168 | 0.26 | Antibacterial | 0.237 0.189 DBMET01702 | ||
| 0.232 | 0.14 | 0.348 | Interleukin 2 agonist | 0.348 0.047 DBMET01702 | DBMET01702 | |
| 0.099 | 0.008 | 0.099 | Nicotinic acid receptor 1 agonist | 0.05 0.02 DBMET01702 | ||
| 0.095 | 0.005 | 0.095 | Retinoid X receptor agonist | 0.056 0.015 DBMET01702 | ||
| 0.097 | 0.009 | 0.097 | H+/K+-transporting ATPase inhibitor | 0.079 0.013 DBMET01702 | ||
| 0.093 | 0.005 | 0.093 | Nicotinic acid receptor agonist | 0.067 0.009 DBMET01702 | ||
| 0.141 | 0.053 | 0.141 | Anesthetic local | 0.122 0.065 DBMET01702 | ||
| 0.131 | 0.045 | 0.154 | Mucolytic | 0.154 0.03 DBMET01702 | DBMET01702 | |
| 0.11 | 0.023 | 0.11 | Aminopeptidase I inhibitor | 0.082 0.041 DBMET01702 | ||
| 0.102 | 0.016 | 0.102 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.084 0.023 DBMET01702 | ||
| 0.232 | 0.147 | 0.232 | Thioredoxin glutathione reductase inhibitor | |||
| 0.117 | 0.033 | 0.117 | ABCA1 expression enhancer | 0.087 0.072 DBMET01702 | ||
| 0.107 | 0.023 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.048 DBMET01702 | ||
| 0.112 | 0.029 | 0.112 | Bile acid receptor antagonist | 0.104 0.041 DBMET01702 | ||
| 0.098 | 0.016 | 0.098 | Peroxisome proliferator-activated receptor gamma antagonist | 0.089 0.023 DBMET01702 | ||
| 0.16 | 0.079 | 0.16 | Neurotensin receptor agonist | |||
| 0.118 | 0.037 | 0.118 | Alcohol dehydrogenase inhibitor | 0.088 0.066 DBMET01702 | ||
| 0.152 | 0.072 | 0.152 | Heat shock protein 90 antagonist | |||
| 0.14 | 0.062 | 0.14 | NADPH oxidase inhibitor | 0.129 0.072 DBMET01702 | ||
| 0.095 | 0.017 | 0.095 | Acyl-CoA dehydrogenase inhibitor | 0.08 0.022 DBMET01702 | ||
| 0.156 | 0.078 | 0.156 | Polo-like kinase-3 inhibitor | 0.154 0.08 DBMET01702 | ||
| 0.132 | 0.054 | 0.176 | Protein-tyrosine phosphatase 1B inhibitor | 0.176 0.036 DBMET01702 | DBMET01702 | |
| 0.177 | 0.1 | 0.177 | Platelet aggregation inhibitor | |||
| 0.097 | 0.023 | 0.097 | Glycine receptor agonist | 0.075 0.046 DBMET01702 | ||
| 0.085 | 0.012 | 0.085 | Protein kinase C theta inhibitor | 0.076 0.017 DBMET01702 | ||
| 0.143 | 0.071 | 0.143 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.117 | 0.046 | 0.117 | Platelet activating factor alpha antagonist | 0.087 0.072 DBMET01702 | ||
| 0.217 | 0.146 | 0.217 | Prostaglandin dehydrogenase inhibitor | |||
| 0.183 | 0.112 | 0.183 | Aryl hydrocarbon receptor agonist | |||
| 0.158 | 0.089 | 0.158 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.114 | 0.047 | 0.114 | MAP kinase 8 inhibitor | |||
| 0.072 | 0.006 | 0.072 | Retinoic acid alpha receptor agonist | 0.058 0.01 DBMET01702 | ||
| 0.143 | 0.079 | 0.163 | MAP kinase 3 inhibitor | 0.163 0.05 DBMET01702 | DBMET01702 | |
| 0.074 | 0.01 | 0.078 | Leukotriene C antagonist | 0.078 0.008 DBMET01702 | DBMET01702 | |
| 0.162 | 0.098 | 0.191 | Hepatoprotectant | 0.191 0.071 DBMET01702 | DBMET01702 | |
| 0.083 | 0.019 | 0.123 | Prostaglandin E2 antagonist | 0.123 0.011 DBMET01702 | DBMET01702 | |
| 0.157 | 0.094 | 0.157 | Amyloid beta precursor protein antagonist | |||
| 0.121 | 0.058 | 0.121 | Caspase 3 inhibitor | |||
| 0.216 | 0.154 | 0.241 | Transcription factor NF kappa B inhibitor | 0.241 0.134 DBMET01702 | DBMET01702 | |
| 0.075 | 0.014 | 0.075 | Purinergic P2Y antagonist | 0.064 0.018 DBMET01702 | ||
| 0.145 | 0.085 | 0.159 | CF transmembrane conductance regulator agonist | 0.159 0.061 DBMET01702 | DBMET01702 | |
| 0.092 | 0.032 | 0.092 | CDC25A inhibitor | 0.082 0.041 DBMET01702 | ||
| 0.093 | 0.034 | 0.093 | Estrogen-related receptor beta agonist | |||
| 0.102 | 0.042 | 0.105 | Ornithine decarboxylase inhibitor | 0.105 0.039 DBMET01702 | DBMET01702 | |
| 0.077 | 0.018 | 0.109 | Phosphorylase inhibitor | 0.109 0.012 DBMET01702 | DBMET01702 | |
| 0.084 | 0.025 | 0.087 | Protein kinase C beta inhibitor | 0.087 0.022 DBMET01702 | DBMET01702 | |
| 0.102 | 0.044 | 0.102 | Histamine N-methyltransferase inhibitor | |||
| 0.187 | 0.129 | 0.26 | Immunostimulant | 0.26 0.092 DBMET01702 | DBMET01702 | |
| 0.08 | 0.022 | 0.08 | Ornithine carbamoyltransferase inhibitor | 0.066 0.028 DBMET01702 | ||
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | 0.063 0.051 DBMET01702 | ||
| 0.246 | 0.189 | 0.246 | Transcription factor inhibitor | |||
| 0.165 | 0.108 | 0.165 | Interleukin antagonist | |||
| 0.064 | 0.009 | 0.064 | GABA uptake inhibitor | 0.052 0.014 DBMET01702 | ||
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | |||
| 0.112 | 0.058 | 0.112 | Interleukin 2 antagonist | |||
| 0.072 | 0.018 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.124 | 0.071 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.233 | 0.18 | 0.233 | 15-Lipoxygenase inhibitor | |||
| 0.071 | 0.018 | 0.071 | Plasminogen activator inhibitor antagonist | 0.054 0.028 DBMET01702 | ||
| 0.119 | 0.068 | 0.119 | Adenylate cyclase inhibitor | 0.107 0.078 DBMET01702 | ||
| 0.072 | 0.021 | 0.072 | Peroxisome proliferator-activated receptor alpha agonist | 0.06 0.026 DBMET01702 | ||
| 0.106 | 0.055 | 0.106 | Anabolic | 0.1 0.062 DBMET01702 | ||
| 0.19 | 0.14 | 0.19 | Streptokinase A inhibitor | |||
| 0.061 | 0.011 | 0.068 | Guanylate cyclase inhibitor | 0.068 0.005 DBMET01702 | DBMET01702 | |
| 0.095 | 0.046 | 0.095 | Bcr-Abl kinase inhibitor | 0.079 0.065 DBMET01702 | ||
| 0.065 | 0.015 | 0.065 | NMDA receptor subunit 3A antagonist | |||
| 0.136 | 0.087 | 0.136 | Thiol protease inhibitor | |||
| 0.135 | 0.086 | 0.168 | MAP3K9 inhibitor | 0.168 0.037 DBMET01702 | DBMET01702 | |
| 0.064 | 0.015 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.108 | 0.06 | 0.108 | Mediator release inhibitor | 0.089 0.082 DBMET01702 | ||
| 0.056 | 0.008 | 0.056 | Retinoid X receptor antagonist | 0.037 0.027 DBMET01702 | ||
| 0.104 | 0.057 | 0.129 | Xanthine oxidase inhibitor | 0.129 0.043 DBMET01702 | DBMET01702 | |
| 0.064 | 0.017 | 0.064 | NMDA receptor subunit 3B antagonist | |||
| 0.055 | 0.009 | 0.055 | Glutamate (mGluR8) agonist | 0.047 0.014 DBMET01702 | ||
| 0.051 | 0.005 | 0.051 | Retinoid X gamma receptor agonist | 0.025 0.014 DBMET01702 | ||
| 0.138 | 0.092 | 0.138 | Src kinase inhibitor | |||
| 0.052 | 0.007 | 0.052 | Purinergic P2Y14 antagonist | 0.038 0.013 DBMET01702 | ||
| 0.173 | 0.128 | 0.173 | ErbB-1 antagonist | |||
| 0.084 | 0.039 | 0.084 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.069 DBMET01702 | ||
| 0.076 | 0.032 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.063 | 0.018 | 0.063 | CXC chemokine 1 receptor antagonist | 0.051 0.035 DBMET01702 | ||
| 0.163 | 0.119 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 DBMET01702 | DBMET01702 | |
| 0.049 | 0.006 | 0.049 | NMDA receptor glycine site antagonist | |||
| 0.083 | 0.039 | 0.083 | MAP kinase kinase 7 inhibitor | 0.079 0.048 DBMET01702 | ||
| 0.253 | 0.21 | 0.38 | Cyclophilin D inhibitor | 0.38 0.103 DBMET01702 | DBMET01702 | |
| 0.064 | 0.022 | 0.064 | Pregnane X receptor antagonist | |||
| 0.124 | 0.082 | 0.124 | Lck kinase inhibitor | |||
| 0.071 | 0.029 | 0.071 | Maillard reaction inhibitor | 0.064 0.032 DBMET01702 | ||
| 0.093 | 0.052 | 0.093 | NMDA receptor antagonist | |||
| 0.049 | 0.007 | 0.049 | Retinoid X alpha receptor antagonist | 0.033 0.025 DBMET01702 | ||
| 0.159 | 0.117 | 0.159 | Focal adhesion kinase 2 inhibitor | 0.144 0.14 DBMET01702 | ||
| 0.116 | 0.074 | 0.116 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.062 | 0.021 | 0.109 | Topoisomerase II beta inhibitor | 0.109 0.008 DBMET01702 | DBMET01702 | |
| 0.046 | 0.005 | 0.046 | Retinoid X beta receptor agonist | 0.022 0.013 DBMET01702 | ||
| 0.064 | 0.023 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.04 DBMET01702 | ||
| 0.055 | 0.014 | 0.055 | Dihydropteroate synthase inhibitor | 0.04 0.027 DBMET01702 | ||
| 0.098 | 0.057 | 0.101 | Interleukin 12 antagonist | 0.101 0.053 DBMET01702 | DBMET01702 | |
| 0.062 | 0.022 | 0.062 | Potassium channel (Inward rectifier) blocker | 0.05 0.035 DBMET01702 | ||
| 0.045 | 0.004 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.035 0.008 DBMET01702 | ||
| 0.09 | 0.051 | 0.095 | Granulocyte macrophage colony stimulating factor agonist | 0.095 0.043 DBMET01702 | DBMET01702 | |
| 0.125 | 0.085 | 0.125 | Protein kinase (CK1) gamma inhibitor | |||
| 0.12 | 0.081 | 0.12 | Antibacterial (Helicobacter pylori) | 0.117 0.086 DBMET01702 | ||
| 0.104 | 0.065 | 0.125 | Expectorant | 0.125 0.047 DBMET01702 | DBMET01702 | |
| 0.122 | 0.083 | 0.122 | Protein-tyrosine kinase Lyn inhibitor | 0.105 0.097 DBMET01702 | ||
| 0.207 | 0.169 | 0.207 | Antithrombotic | 0.201 0.176 DBMET01702 | ||
| 0.085 | 0.048 | 0.085 | T cell inhibitor | |||
| 0.046 | 0.009 | 0.046 | Uridine phosphorylase inhibitor | 0.045 0.01 DBMET01702 | ||
| 0.076 | 0.04 | 0.086 | Carbonic anhydrase VA inhibitor | 0.086 0.032 DBMET01702 | DBMET01702 | |
| 0.08 | 0.043 | 0.08 | GABA B receptor agonist | |||
| 0.043 | 0.007 | 0.043 | Glutamate (mGluR3) agonist | 0.037 0.013 DBMET01702 | ||
| 0.093 | 0.057 | 0.093 | Potassium channel activator | |||
| 0.048 | 0.012 | 0.051 | Leukotriene C4 antagonist | 0.051 0.01 DBMET01702 | DBMET01702 | |
| 0.161 | 0.126 | 0.204 | Hypolipemic | 0.204 0.091 DBMET01702 | DBMET01702 | |
| 0.041 | 0.007 | 0.041 | Retinoic acid receptor agonist | 0.032 0.009 DBMET01702 | ||
| 0.055 | 0.022 | 0.055 | Thymidylate synthase inhibitor | 0.043 0.038 DBMET01702 | ||
| 0.186 | 0.154 | 0.186 | Transcription factor STAT3 inhibitor | 0.181 0.163 DBMET01702 | ||
| 0.188 | 0.156 | 0.188 | Transcription factor STAT inhibitor | |||
| 0.047 | 0.015 | 0.047 | Potassium channel Kv1.1 blocker | |||
| 0.039 | 0.007 | 0.039 | Kainate receptor 5 antagonist | 0.018 0.017 DBMET01702 | ||
| 0.084 | 0.053 | 0.114 | Adrenaline agonist | 0.114 0.029 DBMET01702 | DBMET01702 | |
| 0.174 | 0.143 | 0.174 | Calpain inhibitor | |||
| 0.115 | 0.085 | 0.115 | Cyclooxygenase 2 inhibitor | 0.107 0.096 DBMET01702 | ||
| 0.038 | 0.008 | 0.038 | Kainate receptor 1 antagonist | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | |||
| 0.057 | 0.028 | 0.057 | Heparanase inhibitor | 0.052 0.041 DBMET01702 | ||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.035 DBMET01702 | ||
| 0.033 | 0.004 | 0.033 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET01702 | ||
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | 0.035 0.023 DBMET01702 | ||
| 0.042 | 0.014 | 0.042 | Purinergic P2Y2 antagonist | 0.036 0.02 DBMET01702 | ||
| 0.07 | 0.042 | 0.089 | Carbonic anhydrase V inhibitor | 0.089 0.031 DBMET01702 | DBMET01702 | |
| 0.033 | 0.005 | 0.033 | Retinoic acid beta receptor agonist | 0.024 0.009 DBMET01702 | ||
| 0.048 | 0.02 | 0.048 | Urate transporter 1 inhibitor | |||
| 0.149 | 0.121 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.04 | 0.014 | 0.04 | Peroxisome proliferator-activated receptor delta antagonist | 0.032 0.025 DBMET01702 | ||
| 0.029 | 0.004 | 0.029 | Retinoid X beta receptor antagonist | 0.02 0.015 DBMET01702 | ||
| 0.057 | 0.032 | 0.057 | DNA helicase inhibitor | |||
| 0.06 | 0.035 | 0.078 | Carbonic anhydrase VB inhibitor | 0.078 0.023 DBMET01702 | DBMET01702 | |
| 0.053 | 0.029 | 0.061 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 DBMET01702 | DBMET01702 | |
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR8) antagonist | 0.034 0.028 DBMET01702 | ||
| 0.03 | 0.006 | 0.03 | Retinoic acid alpha receptor antagonist | 0.023 0.011 DBMET01702 | ||
| 0.2 | 0.176 | 0.21 | Vasodilator, peripheral | 0.21 0.165 DBMET01702 | DBMET01702 | |
| 0.03 | 0.006 | 0.03 | Retinoic acid gamma receptor agonist | 0.022 0.016 DBMET01702 | ||
| 0.105 | 0.081 | 0.105 | Cholesterol synthesis inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.027 | 0.004 | 0.027 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.021 0.012 DBMET01702 | ||
| 0.065 | 0.042 | 0.065 | Neuraminidase (influenza) inhibitor | |||
| 0.047 | 0.024 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.032 | 0.01 | 0.032 | Retinoid X gamma receptor antagonist | 0.025 0.024 DBMET01702 | ||
| 0.048 | 0.027 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.044 0.035 DBMET01702 | ||
| 0.046 | 0.025 | 0.046 | Glutamate (mGluR4) antagonist | |||
| 0.05 | 0.03 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.026 DBMET01702 | DBMET01702 | |
| 0.045 | 0.024 | 0.05 | Angiotensin AT1 receptor antagonist | 0.05 0.018 DBMET01702 | DBMET01702 | |
| 0.026 | 0.007 | 0.026 | Retinoic acid receptor antagonist | 0.019 0.012 DBMET01702 | ||
| 0.023 | 0.004 | 0.023 | Thrombopoietin agonist | |||
| 0.049 | 0.031 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET01702 | DBMET01702 | |
| 0.045 | 0.026 | 0.045 | Nerve growth factor antagonist | |||
| 0.032 | 0.014 | 0.032 | NMDA 2D receptor antagonist | |||
| 0.113 | 0.096 | 0.113 | Alkaline phosphatase inhibitor | |||
| 0.037 | 0.02 | 0.037 | Free fatty acid receptor 1 antagonist | 0.032 0.026 DBMET01702 | ||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) agonist | |||
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | |||
| 0.05 | 0.034 | 0.056 | Factor III inhibitor | 0.056 0.023 DBMET01702 | DBMET01702 | |
| 0.067 | 0.052 | 0.067 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.03 | 0.015 | 0.03 | DNA polymerase III inhibitor | |||
| 0.059 | 0.045 | 0.059 | Neuraminidase inhibitor | |||
| 0.199 | 0.185 | 0.199 | Beta lactamase inhibitor | |||
| 0.058 | 0.045 | 0.058 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.06 | 0.047 | 0.06 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.049 DBMET01702 | ||
| 0.038 | 0.026 | 0.038 | Farnesoid X receptor agonist | 0.038 0.026 DBMET01702 | ||
| 0.125 | 0.113 | 0.129 | Adenylate cyclase stimulant | 0.129 0.105 DBMET01702 | DBMET01702 | |
| 0.027 | 0.014 | 0.027 | Vanilloid 2 agonist | 0.026 0.017 DBMET01702 | ||
| 0.065 | 0.053 | 0.065 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.054 | 0.042 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET01702 | DBMET01702 | |
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.185 | 0.173 | 0.185 | MAP kinase kinase 3 inhibitor | |||
| 0.028 | 0.017 | 0.042 | Prostaglandin EP4 antagonist | 0.042 0.01 DBMET01702 | DBMET01702 | |
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.033 | 0.022 | 0.033 | Protein kinase C beta II inhibitor | 0.03 0.028 DBMET01702 | ||
| 0.031 | 0.02 | 0.032 | Elastase 2B inhibitor | 0.032 0.018 DBMET01702 | DBMET01702 | |
| 0.031 | 0.02 | 0.032 | Elastase 3B inhibitor | 0.032 0.018 DBMET01702 | DBMET01702 | |
| 0.031 | 0.02 | 0.032 | Elastase 3A inhibitor | 0.032 0.018 DBMET01702 | DBMET01702 | |
| 0.016 | 0.005 | 0.016 | Retinoic acid beta receptor antagonist | 0.011 0.009 DBMET01702 | ||
| 0.075 | 0.065 | 0.075 | Glycine receptor antagonist | |||
| 0.014 | 0.005 | 0.014 | Retinoic acid receptor gamma antagonist | 0.011 0.009 DBMET01702 | ||
| 0.035 | 0.026 | 0.035 | Kainate receptor 2 antagonist | |||
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.049 | 0.041 | 0.051 | Prostaglandin antagonist | 0.051 0.039 DBMET01702 | DBMET01702 | |
| 0.076 | 0.068 | 0.076 | Glutathione S-transferase inhibitor | |||
| 0.052 | 0.044 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.034 DBMET01702 | DBMET01702 | |
| 0.023 | 0.015 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.104 | 0.096 | 0.104 | Transcription factor STAT6 inhibitor | |||
| 0.036 | 0.029 | 0.039 | TRPM8 blocker | 0.039 0.026 DBMET01702 | DBMET01702 | |
| 0.051 | 0.044 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.021 | 0.015 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.064 | 0.058 | 0.064 | MDM2 inhibitor | |||
| 0.089 | 0.083 | 0.089 | Falcipain 3 inhibitor | |||
| 0.014 | 0.008 | 0.014 | DNA polymerase III polC-type inhibitor | |||
| 0.033 | 0.027 | 0.037 | Angiotensin II receptor antagonist | 0.037 0.018 DBMET01702 | DBMET01702 | |
| 0.049 | 0.043 | 0.049 | Thromboxane antagonist | |||
| 0.183 | 0.177 | 0.183 | Thyroid hormone antagonist | |||
| 0.062 | 0.056 | 0.062 | Potassium channel large-conductance Ca-activated activator | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.049 | 0.044 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.089 | 0.084 | 0.095 | Monophenol monooxygenase inhibitor | 0.095 0.08 DBMET01702 | DBMET01702 | |
| 0.025 | 0.02 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.034 | 0.029 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.045 | 0.04 | 0.045 | Thromboxane A2 antagonist | |||
| 0.022 | 0.017 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.013 DBMET01702 | DBMET01702 | |
| 0.038 | 0.034 | 0.042 | Thymidine kinase inhibitor | 0.042 0.026 DBMET01702 | DBMET01702 | |
| 0.025 | 0.02 | 0.025 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.046 | 0.042 | 0.046 | NMDA 2A receptor antagonist | |||
| 0.031 | 0.027 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.035 | 0.031 | 0.035 | DNA gyrase subunit B inhibitor | |||
| 0.025 | 0.022 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.017 | 0.015 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.024 | 0.022 | 0.024 | Thyroid hormone agonist | |||
| 0.09 | 0.088 | 0.09 | Folate antagonist | |||
| 0.025 | 0.023 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DBMET01702 | DBMET01702 | |
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.03 DBMET01702 | ||
| 0.075 | 0.074 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.031 | 0.03 | 0.031 | Glutamate (mGluR4) agonist | |||
| 0.093 | 0.092 | 0.093 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.056 | 0.057 | 0.074 | Leukotriene antagonist | 0.074 0.037 DBMET01702 | DBMET01702 | |
| 0.109 | 0.114 | 0.123 | Cytidine deaminase inhibitor | 0.123 0.098 DBMET01702 | DBMET01702 | |
| 0.087 | 0.092 | 0.093 | AMP-activated protein kinase stimulant | 0.093 0.08 DBMET01702 | DBMET01702 | |
| 0.056 | 0.062 | 0.095 | Leukotriene synthesis inhibitor | 0.095 0.029 DBMET01702 | DBMET01702 | |
| 0.079 | 0.087 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.077 DBMET01702 | DBMET01702 | |
| 0.012 | 0.022 | 0.02 | Prostaglandin EP1 antagonist | 0.02 0.014 DBMET01702 | DBMET01702 | |
| 0.152 | 0.163 | 0.191 | Antioxidant | 0.191 0.121 DBMET01702 | DBMET01702 | |
| 0.08 | 0.091 | 0.091 | Glutamate release inhibitor | 0.091 0.059 DBMET01702 | DBMET01702 | |
| 0.033 | 0.044 | 0.047 | Liver X receptor alpha agonist | 0.047 0.022 DBMET01702 | DBMET01702 | |
| 0.02 | 0.033 | 0.039 | Liver X receptor beta antagonist | 0.039 0.013 DBMET01702 | DBMET01702 | |
| 0.035 | 0.052 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET01702 | DBMET01702 | |
| 0.045 | 0.063 | 0.062 | Glucosylceramidase inhibitor | 0.062 0.028 DBMET01702 | DBMET01702 | |
| 0.04 | 0.059 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.035 DBMET01702 | DBMET01702 | |
| 0.074 | 0.095 | 0.082 | Bromodomain-containing protein 2 inhibitor | 0.082 0.072 DBMET01702 | DBMET01702 | |
| 0.054 | 0.084 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.049 DBMET01702 | DBMET01702 | |
| 0.079 | 0.113 | 0.099 | DNA polymerase I inhibitor | 0.099 0.087 DBMET01702 | DBMET01702 | |
| 0.09 | 0.125 | 0.103 | Toll-Like receptor 2 antagonist | 0.103 0.099 DBMET01702 | DBMET01702 | |
| 0.019 | 0.058 | 0.031 | Liver X receptor beta agonist | 0.031 0.027 DBMET01702 | DBMET01702 | |
| 0.077 | 0.126 | 0.121 | Alkylator | 0.121 0.067 DBMET01702 | DBMET01702 | |
| 0.03 | 0.083 | 0.04 | Guanylate cyclase stimulant | 0.04 0.038 DBMET01702 | DBMET01702 | |
| 0.064 | 0.125 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.035 DBMET01702 | DBMET01702 | |
| 0.15 | 0.219 | 0.19 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.164 DBMET01702 | DBMET01702 | |
| 0.167 | 0.236 | 0.246 | Apoptosis antagonist | 0.246 0.132 DBMET01702 | DBMET01702 | |
| 0.093 | 0.167 | 0.18 | Angiogenesis stimulant | 0.18 0.105 DBMET01702 | DBMET01702 | |
| 0.117 | 0.241 | 0.202 | Hypoglycemic | 0.202 0.11 DBMET01702 | DBMET01702 | |
| 0.011 | 0.136 | 0.03 | Liver X receptor alpha antagonist | 0.03 0.018 DBMET01702 | DBMET01702 | |
| 0.011 | 0.143 | 0.028 | Liver X receptor antagonist | 0.028 0.025 DBMET01702 | DBMET01702 | |
| 0.017 | 0.379 | 0.072 | Phosphodiesterase 3A inhibitor | 0.072 0.068 DBMET01702 | DBMET01702 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |